发明名称 Variant, Recombinant Beta-Glucocerebrosidase Proteins With Increased Stability And Increased Retained Catalytic Activity
摘要 Described herein are variant, recombinant β-glucocerebrosidase proteins characterized as having increased stability relative to recombinant wild-type β-glucocerebrosidase. Also provided herein are variant, recombinant β-glucocerebrosidase proteins characterized as retaining more catalytic activity relative to recombinant wild-type β-glucocerebrosidase. Further described herein are variant, recombinant β-glucocerebrosidase proteins that can have amino acid variations at one or more of the following positions: 316, 317, 321 and 145. Methods of making the variant, recombinant β-glucocerebrosidase proteins are also described as well as methods of treating patients having lysosomal storage diseases.
申请公布号 US2015216950(A1) 申请公布日期 2015.08.06
申请号 US201514611495 申请日期 2015.02.02
申请人 Amicus Therapeutics, Inc. 发明人 Do Hung V.
分类号 A61K38/47;C12N9/24 主分类号 A61K38/47
代理机构 代理人
主权项 1. A variant, recombinant human β-glucocerebrosidase protein, wherein the protein has at least one of the following substitutions relative to SEQ ID NO: 1: F316A, L317F, K321V, K321A, H145L and H145F.
地址 Cranbury NJ US